Skye Bioscience, Inc. (SKYE) vs Exicure, Inc. (XCUR)
- Skye Bioscience, Inc. SKYE 1.55 −2.52%
- Exicure, Inc. XCUR 1.11 −0.89%
Skye Bioscience, Inc. and Exicure, Inc. are both Biotechnology companies. Skye Bioscience, Inc. and Exicure, Inc. are of similar size ($7.3M and $7.0M). Across the 10 metrics below, Exicure, Inc. leads on 8 and Skye Bioscience, Inc. on 2.
Valuation
Profitability
| Metric | SKYE | XCUR | Biotechnology median |
|---|---|---|---|
| Gross margin | 68.04% | 80.08% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (233.87%) | (168.37%) | (56.36%) |
| Return on assets | (159.80%) | (54.98%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack